Left ventricular mass changes after renal transplantation: Influence of dietary sodium and change in serum uric acid

Transplantation

Volumn 98, Issue 2, 2014, Pages 202-207

  Du Cailar, Guilhem ^a   Oudot, Carole ^a   Fesler, Pierre ^a   Mimran, Albert ^a   Bonnet, Benjamin ^a   Pernin, Vincent ^a   Ribstein, Jean ^a   Mourad, Georges ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Dietary sodium; Left ventricular hypertrophy; Renal function; Uric acid

Indexed keywords

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; DIET, SODIUM-RESTRICTED; FEMALE; FRANCE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SODIUM CHLORIDE, DIETARY; TIME FACTORS; TREATMENT OUTCOME; URIC ACID;

EID: 84904663746     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000043     Document Type: Article

References (44)

1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
2. Berthoux F, Mariat C. Cardiovascular death after renal transplantation remains the first cause despite significant quantitative and qualitative changes. Transplantation 2010; 89: 806.
3. Ojo AO, Hanson JA, Wolfe RA, et al. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57: 307.
4. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovasculardisease. Circulation 2003; 108: 2154.
5. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echo-cardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561.
6. Parfrey PS, Foley RN, Harnett JD, et al. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11: 1277.
7. Mancini GB, Dahlöf B, Díez J. Surrogate markers for cardiovascular disease: structural markers. Circulation 2004; 109(25 Suppl 1): 22.
8. Rigatto C, Foley R, Jeffery J, et al. Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol 2003; 14: 462.
9. Montanaro D, Gropuzzo M, Tulissi P, et al. Effects of successful renal transplantation on left ventricular mass. Transplant Proc 2005; 37: 2485.
10. Arnol M, Knap B, Oblak M, et al. Subclinical left ventricular echo-cardiographic abnormalities 1 year after kidney transplantation are associated with graft function and future cardiovascular events. Transplant Proc 2010; 42: 4064.
11. Patel RK, Mark PB, Johnston N, et al. Renal transplantation is not associated with regression of left ventricular hypertrophy: a magnetic resonance study. Clin J Am Soc Nephrol 2008; 3: 1807.
12. du Cailar G, Mimran A, Fesler P, et al. Dietary sodium and pulse pressure in normotensive and essential hypertensive subjects. J Hypertens 2004; 22: 697.
13. du Cailar G, Mimran A. Non-pressure-related effects of dietary sodium. Curr Hypertens Rep 2009; 11: 12.
14. Chadban S, Chan M, Fry K, et al. The CARI guidelines. Nutritional management of hypertension in adult kidney transplant recipients. Nephrology 2010; 15(Suppl 1): 56.
15. van den Berg E, Geleijnse JM, Brink EJ, et al. Sodium intake and blood pressure in renal transplant recipients. Nephrol Dial Transplant 2012; 27: 3352.
16. du Cailar G, Fesler P, Ribstein J, et al. Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system. Hypertension 2010; 56: 865.
17. du Cailar G, Ribstein J, Mimran A. Dietary sodium and target organ damage in essential hypertension. Am J Hypertens 2002; 15: 222.
18. Paoletti E, Marsano L, Bellino D, et al. Effect of everolimus on left ventricular hypertrophy of de novo kidney transplant recipients: a 1 year, randomized, controlled trial. Transplantation 2012; 93: 503.
19. Caliskan Y, Gorgulu N, Yelken B, et al. Serum uric acid level is associated with cardiac hypertrophy in renal transplant recipients. Clin Transplant 2011; 25: 368.
20. Kalantar E, Khalili N, Hossieni MS, et al. Hyperuricemia after renal transplantation. Transplant Proc 2011; 43: 584.
21. Liefeldt L, Budde K. Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk. Transpl Int 2010; 23: 1191.
22. Forman JP, Scheven L, de Jong PE, et al. Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension. Circulation 2012; 125: 3108.
23. Dahle DO, Midtvedt K, Hartmann A, et al. Endothelial dysfunction is associated with graft loss in renal transplant recipients. Transplantation 2013; 95: 733.
24. Devereux RB, Wachtell K, Gerdts E, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004; 292: 2396.
25. Himelman RB, Landzberg JS, Simonson JS, et al. Cardiac consequences of renal transplantation: changes in left ventricular morphology and function. J Am Coll Cardiol 1988; 12: 915.
26. Hüting J. Course of left ventricular hypertrophy and function in endstage renal disease after renal transplantation. Am J Cardiol 1992; 70: 1481.
27. Chan CT, Greene T, Chertow GM, et al. Frequent Hemodialysis Network (FHN) Trial Group. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging 2012; 5: 251.
28. Vaidya OU, House JA, Coggins TR, et al. Effect of renal transplantation for chronic renal disease on left ventricular mass. Am J Cardiol 2012; 110: 254.
29. Iqbal MM, Rashid HU, Banerjee SK, et al. Changes in cardiac parameters of renal allograft recipients: a compilation of clinical, laboratory, and echocardiographic observations. Transplant Proc 2008; 40: 2327.
30. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. Nephrol Dial Transplant 2002; 17: 1.
31. Artham SM, Lavie CJ, Milani RV, et al. Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis 2009; 52: 153.
32. Ferreira SR, Moisés VA, Tavares A, et al. Cardiovascular effects of successful renal transplantation: a 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile. Transplantation 2002; 74: 1580.
33. Prasad GV, Ruzicka M, Burns KD, et al. Hypertension in dialysis and kidney transplant patients. Can J Cardiol 2009; 25: 309.
34. Rodriguez CJ, Bibbins-Domingo K, Jin Z, et al. Association of sodium and potassium intake with left ventricular mass: coronary artery risk development in young adults. Hypertension 2011; 58: 410.
35. He FJ, Markandu ND, Sagnella GA, et al. Plasma sodium: ignored and underestimated. Hypertension 2005; 45: 98.
36. Zoccali C, Maio R, Mallamaci F, et al. Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 2006; 17: 1466.
37. Jablonski KL, Racine ML, Geolfos CJ, et al. Dietary sodium restriction reverses vascular endothelial dysfunction in middle-aged/older adults with moderately elevated systolic blood pressure. J Am Coll Cardiol 2013; 61: 335.
38. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117: 568.
39. Pimenta E, Gaddam KK, Oparil S, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009; 54: 475.
40. Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362: 590.
41. Vetromile F, Szwarc I, Garrigue V, et al. Early high pulse pressure is associated with graft dysfunction and predicts poor kidney allograft survival. Transplantation 2009; 88: 1088.
42. Fesler P, Du Cailar G, Ribstein J, et al. Left ventricular remodeling and renal function in never-treated essential hypertension. J Am Soc Nephrol 2003; 14: 881.
43. Du Cailar G, Ribstein J, Daures JP, et al. Sodium and left ventricular mass in untreated hypertensive and normotensive subjects. Am J Physiol 1992; 263: 177.
44. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613.